• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET advocates press second scan coverage

Article

The Centers for Medicare and Medicaid Services (CMS) believes one PET scan is enough when doing a patient’s initial treatment evaluation, but seven medical imaging groups disagree.

PET advocates press second scan coverage
The Centers for Medicare and Medicaid Services (CMS) believes one PET scan is enough when doing a patient’s initial treatment evaluation, but seven medical imaging groups disagree. The groups this week signed a joint letter to CMS formally requesting coverage of two fluorodeoxyglucose (FDG) scans per patient under certain circumstances. They argued that limiting coverage to just one may be contrary to good clinical practice. Three examples underscoring the need for a second initial FDG/PET scan were highlighted in the letter, signed by the leadership of the National Oncologic PET Registry Working Group, the Academy of Molecular Imaging, the American College of Nuclear Medicine, the American College of Radiology, the American Society for Radiation Oncology, the Institute for Molecular Technologies and SNM. The first addresses the use of PET for the diagnosis or staging of a tumor when the course of treatment is determined to be radiation therapy and another PET scan is needed for successful radiation therapy planning. The second is when PET returns a false-negative when evaluating a suspicious lesion for a patient later diagnosed with cancer and another scan is needed for staging before treatment. The third applies to patients with newly diagnosed cancer who had to delay treatment and another scan is required to evaluate the disease after a prolonged period of time.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.